by PVA_Admin | Jul 20, 2023 | Cold Plasma Publications, Publications
The First Cold Atmospheric Plasma Phase I Clinical Trial for the Treatment of Advanced Solid Tumors: A Novel Treatment Arm for Cancer Jerome Canady, Saravana R. K. Murthy, Taisen Zhuang, Steven Gitelis, Aviram Nissan, Lawan Ly, Olivia Z. Jones, Xiaoqian Cheng,...
by PVA_Admin | Jun 29, 2023 | 2023 Press Release, Press Release
USMI Receives FDA Approval for New Robotic Surgery Device – The Canady Flex RoboWrist™ TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI), a Biomedical and Life Science subsidiary of US Patent Innovations, LLC, announced today it has...
by PVA_Admin | Jun 15, 2023 | 2023 Press Release, Press Release
JCRI-ABTS and USMI Reports Statistically Significant Results of the Canady Helios Cold Plasma Phase 1 Clinical Trial on Patients with Stage 4 and Recurrent Advanced Solid Tumors TAKOMA PARK, Md.–(BUSINESS WIRE)—June 15, 2023 – The Jerome Canady Research...
by PVA_Admin | Sep 21, 2022 | 2022 Press Release, Press Release
2022 US Medical Innovations Raises $10.2 M in Private Placement TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI), a subsidiary of US Patent Innovations, LLC, announced today it has secured a $10.2 million private placement deal from...
by PVA_Admin | Jun 16, 2022 | Cold Plasma Publications, Publications
Canady Cold Helios Plasma Reduces Soft Tissue Sarcoma Viability by Inhibiting Proliferation, Disrupting Cell Cycle, and Inducing Apoptosis: A Preliminary Report Lawan Ly, Xiaoqian Cheng, Saravana R. K. Murthy, Olivia Z. Jones, Taisen Zhuang, Steven Gitelis, Alan T....
